Blinatumomab

(Synonyms: bscCD19xCD3; AMG-103; MEDI-538; MT-103; BLINCYTO)
3 Cited Publications
Customer Review

Based on 3 publication(s) in Google Scholar

Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia.

For research use only. We do not sell to patients.

  • Purity: 97.33%
  • CAS No.: 853426-35-4
  • Molecular Weight:54.09 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
Customer Validation & Images
Others
  • Others
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00